Medicinální Oxid Dusný Sol (Nitrous Oxide)

Nitrous oxide works by blocking NMDA receptors, which reduces excitatory neurotransmission, and by promoting the release of endogenous opioids that activate μ‑opioid receptors. This dual action diminishes pain signals and induces a calming, sedative effect without completely suppressing respiratory drive in most patients.

The specific concentration and duration of nitrous oxide are determined by the prescribing clinician based on the procedure and patient characteristics. It is typically delivered as a calibrated mixture with oxygen, ranging from 30 % to 70 % nitrous oxide, and the dose is adjusted to achieve the desired analgesic effect while maintaining safety.

Safety data for nitrous oxide in pregnancy and lactation are limited. It should only be used when the expected benefit to the mother outweighs any potential risk to the fetus or infant. Clinicians should assess each case individually and follow local guidelines regarding its use during pregnancy or while breastfeeding.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements) and assists with import documentation.

Nitrous oxide offers rapid, titratable analgesia with a short recovery time, making it useful for brief procedures. Compared with intravenous opioids, it has a lower risk of respiratory depression and nausea, but provides less profound analgesia. Inhalational agents like sevoflurane produce deeper sedation but require more extensive monitoring and equipment.

Store nitrous oxide cylinders at ambient temperature, preferably below 25 °C, in an upright position. Keep them in a well‑ventilated area away from direct sunlight, heat sources and open flames. Protect the cylinders from physical damage and ensure that only trained personnel handle the gas using appropriate delivery systems.

Nitrous oxide is administered via a calibrated delivery system that mixes the gas with oxygen, usually through a face mask or nasal hood. The clinician adjusts the concentration to achieve the desired analgesic effect while continuously monitoring the patient’s vital signs and oxygen saturation throughout the procedure.

The most serious risks include hypoxia if insufficient oxygen is delivered, respiratory depression or apnea, loss of consciousness, severe hypertension or arrhythmias, and rare allergic reactions. Prompt recognition and immediate supportive measures, such as providing supplemental oxygen and airway management, are essential to mitigate these risks.

Nitrous oxide is contraindicated in patients with severe chronic obstructive pulmonary disease, untreated pneumothorax, known vitamin B12 deficiency, or those who are unable to protect their airway. It should also be avoided in individuals with a history of malignant hyperthermia or in whom the use of inhalational anesthetics is otherwise prohibited.